2017
DOI: 10.7860/jcdr/2017/27430.9859
|View full text |Cite
|
Sign up to set email alerts
|

Hypolipidaemic Effects of Gymnema Sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar Rats

Abstract: Introduction: Hyperlipidaemia is a well known risk factor for cardiovascular diseases. Lifestyle modification can be the initial step to reduce cholesterol levels. There are various drugs which are used to control dyslipidaemia. Treatment of lipid abnormalities is a lifelong battle. Moreover, the safety and effectiveness of long term lipid lowering treatment are questionable. Gymnema Sylvestre (GS) is a well known herb with various medicinal properties. Aim:To explore the hypolipidaemic activity of GS leaves e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 15 publications
1
5
0
Order By: Relevance
“…These results also demonstrate that the rats are hyperglycemic and hyperlipidemic, a typical biochemical picture associated with Type 2 diabetes. Our results are supported by Singh et al (2017); Abdul-Ghani and Defronzo (2010), who have demonstrated that HFD fed rats for four weeks provoked obesity and dyslipidaemia. Gymnemic acid or metformin treatment in group III or group IV rats in our study showed a signi icant decrease in body weight, fasting blood glucose and lipid pro ile.…”
Section: Figure 6: Impact Of Gymnemic Acid On the Protein Expression supporting
confidence: 88%
See 1 more Smart Citation
“…These results also demonstrate that the rats are hyperglycemic and hyperlipidemic, a typical biochemical picture associated with Type 2 diabetes. Our results are supported by Singh et al (2017); Abdul-Ghani and Defronzo (2010), who have demonstrated that HFD fed rats for four weeks provoked obesity and dyslipidaemia. Gymnemic acid or metformin treatment in group III or group IV rats in our study showed a signi icant decrease in body weight, fasting blood glucose and lipid pro ile.…”
Section: Figure 6: Impact Of Gymnemic Acid On the Protein Expression supporting
confidence: 88%
“…Gymnemic acid or metformin treatment in group III or group IV rats in our study showed a signi icant decrease in body weight, fasting blood glucose and lipid pro ile. (Kim et al, 2017;Singh et al, 2017) have proved that mice fed with G. Sylvestre extract (500 mg/kg) demonstrate less food and energy ef iciency ratios and less body weight gain when scrutinized with the HFD alone fed group.…”
Section: Figure 6: Impact Of Gymnemic Acid On the Protein Expression mentioning
confidence: 99%
“…Both the doses were however inferior to Atorvastatin 10mg/kg. 20 Shanmugasundaram ERB et al conducted a clinical study on 27 patients of Type 1 diabetes on insulin. They found that serum lipids returned to near normal after 10-12 months of treatment.…”
Section: Discussionmentioning
confidence: 99%
“…They can act as Islah-e-Jigar (Hepatoprotective), Muhallil-e-Auram (Anti-inflammatory), Mudirr-e-Baul (Diuretic) and Antioxidant. They can also balance the Akhlat (Humors), such as Badyan (Foeniculm vulgare) [37] , Bikh Ajmod (Apium graveolens) [38] , Gudmar Booti (Gymnema sylvestre) [39] , Halela (Terminalia chebula) [40,41] , Lehsun (Allium sativum) [42,43] , Kaloonji (Nigella Sativa) [42] , Luk Maghsul (Laccifer lacca) [43] , Methi (Trigonella foenum-graecum) [44] , Sandrus (Trachelobium hornemanianum), Saad kofi (Cyperus rotundus), Soya (Anethum sowa) [45] , Sumbuluttib (Valeriana officinalis), Tukhme Karafs (Apium graveolens) [46] and Tukhme Suddab (Ruta graveolens) [47] Kasni (Cichorium intybus) [47] , Maku (Solanum nigrum) [48] , Afsanteen (Artemisia absinthium) [49] , Muquil (Commiphora mukul) [50] , Chhal Arjun (Terminalia arjuna) [51] , Badranjboya (Mellisa officinalis) [52] , Abresham (Bombyx mori) [53] , which have been reported as having antihyperlipidemic activity. Various Unani formulation have been used by physicians, based on their clinical experiences, to manage dyslipidemia and Farbahi such as Safoof Kalonji [54] , Habbe Sundarus [35] , Qurs Luk [55] , Itriphal Sagheer [56] , Majoon Sheer Alvi Khan [57] and Safoof Muhazzil [58,59] .…”
Section: Ilaj Bil Dawa (Pharmacotherapy)mentioning
confidence: 99%